4 Jun 2026

Reference: CIR-2026-00000088

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

Circular No. (22/2026) Recall of All Batches of the Medical Product ROSA 10mg and 20mg Film-Coated Tablets (Rosuvastatin)

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Recall of All Batches of ROSA 10 mg and ROSA 20 mg Film-Coated Tablets (Rosuvastatin).pdf

download